Remote Monitoring Program Cuts Heart Failure Readmissions in Half
UMass Memorial Health–Harrington Hospital reduced 30-day readmissions for congestive heart failure by 50% using artificial intelligence and remote care teams.
A remote monitoring program launched by UMass Memorial Health–Harrington led to a 50% reduction in 30-day readmissions for patients with
The program utilizes Brook Health’s artificial intelligence (AI)–powered platform, combining AI with human care teams to monitor patients remotely, helping to reduce unnecessary hospitalizations and improve patient outcomes.
Through the program, patients are equipped with internet-connected scales and blood pressure cuffs, allowing them to track their weight and blood pressure from home. Data from these devices are automatically sent to the Brook Health app, where nurses monitor patient information in real time. The care teams are then able to intervene early, providing education, troubleshooting, and care coordination.
According to Oren Nissim, CEO and cofounder of Brook Health, this approach empowers care teams to provide more personal care for congestive heart failure while breaking through the location barrier.
“This forward-thinking approach demonstrates how technology and human expertise can combine to extend the reach of healthcare teams, ensuring patients receive timely, personalized care even when resources are stretched,” Nissim said. “The success at Harrington is a testament to what's possible when innovative healthcare leaders embrace new models of care delivery."
It’s important to note that no accompanying study was made available to verify the findings at the time of publication.
The remote monitoring program at UMass Memorial Health is part of a broader push to implement similar programs for other chronic conditions, including chronic obstructive pulmonary disease (COPD), diabetes, and hypertension. By enabling patients to track their health data from home, these programs aim to reduce hospitalizations and improve the long-term management of chronic diseases. This digital health initiative helps bridge the gap in health care access, particularly as health systems continue to face staffing shortages.
Remote patient monitoring has proven to be a powerful tool in managing chronic diseases.
Collectively, these findings further underscore the growing role of remote monitoring in improving patient outcomes for chronic conditions. As health care systems continue to adopt these technologies, the integration of AI and real-time data monitoring could change the management of diseases like heart failure and hypertension.
References
- UMass Memorial Health - Harrington announces results of remote monitoring program for congestive heart failure using Brook Health's remote care platform. News release. Brook Health. October 8, 2024. Accessed October 10, 2024. https://www.prnewswire.com/news-releases/umass-memorial-health--harrington-announces-results-of-remote-monitoring-program-for-congestive-heart-failure-using-brook-healths-remote-care-platform-302269844.html
- Remote monitoring and pharmacist helped improve hard-to-control blood pressure. American Heart Association. September 5, 2024. Accessed October 10, 2024. https://newsroom.heart.org/news/remote-monitoring-and-pharmacist-helped-improve-hard-to-control-blood-pressure
- Grossi G. Research explores integration of remote monitoring for HF, heart transplant allocation impact. The American Journal of Managed Care®. October 9, 2024. Accessed October 10, 2024. https://www.ajmc.com/view/research-explores-integration-of-remote-monitoring-for-hf-heart-transplant-allocation-impact
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025